About Us Clinical Programs Education Programs Events Consumer Products Research Related Links
History
Sponsorship
Faculty
Alumni
Annual Report
Current News
Archived News
What's New
SUBJECT: The 3-Minute Interview: Linda Simoni-Wastila
SOURCE: The (Baltimore) Examiner – Aug. 29
SUMMARY: Linda Simoni-Wastila, BSPharm, PhD
, is an associate research professor at the School of Pharmacy and director of the Long-Term Care Initiative at the School’s Peter Lamy Center. She spoke to The Examiner recently about the dangers of addiction to painkillers. Prescriptions of opium derivatives including codeine, morphine, oxycodone and hydrocodone have doubled in the last 10 years.

http://www.examiner.com/a-905163~The_3_minute_interview___Linda_Simoni_Wastila.html

********************************

SUBJECT: University of Maryland Faculty Member Appointed to MedPAC
SOURCE: AACP News – July issue
SUMMARY: Bruce Stuart, PhD
, professor and executive director of the Peter Lamy Center on Drug Therapy and Aging at the School of Pharmacy  is one of three new members of the Medicare Payment Advisory Commission (MedPAC). His term ends in 2009.

http://www.aacp.org/Docs/MainNavigation/NewsRoom/8453_AACPJuly07.pdf

********************************

SUBJECT: On the Way Up
SOURCE: The (
Baltimore) Examiner - June 1
SUMMARY
: Bruce Stuart, PhD, professor and executive director of the Peter Lamy Center on Drug Therapy and Aging at the School of Pharmacy, has been appointed to the federal Medicare Payment Advisory Commission.
 

********************************

SUBJECT: On the Move: Stuart Appointed

SOURCE: The Daily Record – June 15

SUMMARY: Bruce Stuart, professor and executive director of the Peter Lamy Center on Drug Therapy and Aging at the School of Pharmacy, has been appointed to the federal Medicare Payment Advisory Commission. An experienced research investigator, Stuart has directed grants and contracts with various federal agencies, private foundations, state governments, and corporations. The 17-member commission advises Congress on issues affecting Medicare.

http://www.mddailyrecord.com/article.cfm?category=1&page=21&id=136041&type=Daily

********************************

SUBJECT: Four-dollar Prescriptions Start Today in Wisconsin Wal-Marts

SOURCE: The Milwaukee Journal Sentinel – Nov. 28, 2006

SUMMARY: Wal-Mart Stores Inc. will begin selling about 140 generic drugs for $4 in Wisconsin today as it rolls out the discount program to 11 additional states. Bruce Stuart, PhD, professor at the School of Pharmacy and director of the Peter Lamy Center for Drug Therapy and Aging, said that he did not expect many people to head to Wal-Mart to save a few dollars on a generic medication. But he added, "It is significant because it has shaken up the market."

http://www.jsonline.com/story/index.aspx?id=535594

 

********************************

SUBJECT: Four-dollar Generics Arrive in Maryland

SOURCE: The (Baltimore) Sun –  Oct. 27, 2006

SUMMARY: As Wal-Mart and Wegmans drop the prices on many generic prescription drugs, Bruce Stuart, PhD, a professor at the School of Pharmacy, said the cut-rate programs should boost use of generics. But, he said, the low-cost generics don't change the high prices of brand-name drugs.

http://www.baltimoresun.com/news/health/bal-te.bz.walmart27oct27,0,4447454.story?page=1&coll=bal-home-headlines

 

********************************

SUBJECT: Meijer Offers Free Antibiotics

SOURCE: The Detroit News – Oct. 24, 2006

SUMMARY: Meijer Inc., a Michigan-based retailer that has joined the battle to lure shoppers with cheap drugs is promising to dole out free prescription antibiotics to all of its customers. The deal comes weeks after Wal-Mart Inc. grabbed national headlines with an announcement that it would fill some generic prescriptions for $4. “Wal-Mart’s move last month changed the way major retailers run their pharmacy departments,” said Bruce Stuart, PhD, professor at the School of Pharmacy.

http://www.detnews.com/apps/pbcs.dll/article?AID=/20061024/LIFESTYLE03/610240387

 

********************************

SUBJECT: Names in the News

SOURCE: The (Baltimore) Sun, Sept. 29, 2006

SUMMARY:  Ilene Zuckerman, PharmD, PhD, an associate professor in the department of pharmaceutical health services research at the School of Pharmacy, has been appointed associate dean for research and graduate education at the School.

********************************

SUBJECT: Pharmacy Services Tighten Up

SOURCE: The Detroit News – July 31, 2006

SUMMARY: Disputes between major drugstore chains and local insurance companies have already left more than 230,000 people in Detroit with fewer pharmacy choices. “It will likely take years for the full effects of the changing marketplace to play out,” said Bruce Stuart, PhD, professor at the School of Pharmacy and executive director of the Peter Lamy Center for Drug Therapy and Aging. http://www.detnews.com/apps/pbcs.dll/article?AID=/20060731/BIZ/607310328/1040/LIFESTYLE03

********************************

SUBJECT: Pharmacist Helps With Medicare Drug Plan Enrollment

SOURCE: WMAR-TV, Ch 2,  5:50 a.m. & 6:12 a.m. – May 12, 2006

SUMMARY: Millions of people, mostly senior citizens, must figure out by midnight Monday which of the numerous prescription drug plans is best for their medicines under the new Medicare Part D guidelines.  Nicole Brandt, PharmD, director of clinical and educational programs at the Peter Lamy Center for Drug Therapy and Aging at the School of Pharmacy, was a guest on two segments of the morning newscast and answered questions from viewers about the different plans and the enrollment process.

(To view a video of this story click here or contact the Communications Office at ext. 6-7820.)

********************************

SUBJECT: Seniors Can Expect More Calculations, Higher Costs as Drug Plan Evolves  

SOURCE: South Florida Sun-Sentinel – May 8, 2006

SUMMARY: May 15 is the deadline to enroll in Medicare’s prescription benefit plan this year, but the program will likely change again as early as 2007 and will continue to evolve over the next few years. Bruce Stuart, PhD, professor at the School of Pharmacy and executive director of the Peter Lamy Center for Drug Therapy and Aging, thinks more dramatic changes will come in 2008, as plan rates initially may be unrealistically low in order to lure more customers.
http://www.sun-sentinel.com/news/local/southflorida/sfl-hlpmedfuture08may08,0,178680.story?coll=sfla-home-headlines

********************************

SUBJECT: Medicare Surprise

SOURCE: Businessweek.com – April 26, 2006

SUMMARY: Some Medicare prescription drug recipients have fallen into what’s being called the “doughnut hole.” Under Part D, once patients reach $2,250 spent on drugs, their coverage ends, and they must pay for their medicine themselves. Benefits resume only after patients pay $5,100—leaving a $2,850 gap. “It is pretty clear that people are going to cut back when they are in the doughnut hole,” says Bruce Stuart, PhD, professor at the School of Pharmacy and executive director of the Peter Lamy Center on Drug Therapy and Aging.

http://www.businessweek.com/magazine/content/06_18/b3982059.htm

********************************

SUBJECT: Medicare Drug Plan’s “Doughnut Hole”

SOURCE: The Frontrunner (Bulletin News Network, Washington, D.C.) – April 24, 2006

SUMMARY: Some Medicare prescription drug recipients have fallen into what’s being called the “doughnut hole.” Under Part D, once patients reach $2,250 spent on drugs, their coverage ends, and they must pay for their medicine themselves. Benefits resume only after patients pay $5,100—leaving a $2,850 gap. About 38 percent of Medicare beneficiaries are at risk, says Bruce Stuart, PhD, professor at the School of Pharmacy and executive director of the Peter Lamy Center on Drug Therapy and Aging.

(For a copy of this story, please call the Communications Office at 6-7820.)

********************************

SUBJECT: What Price to Save a Life         

SOURCE: The Baltimore Sun – Feb. 19 , 2006

SUMMARY: School of Pharmacy Associate Professor Linda Simoni-Wastila, PhD, comments on a California drug maker’s plans to charge as much as $100,000 per year for an experimental cancer treatment.

http://www.baltimoresun.com/business/bal-bz.drugs19feb19,0,2719205.story?coll=bal-business-headlines

 ********************************

The Lamy Initiative: Promoting Research and Awareness Of Medication Issues in Long-Term Care Facilities
Click above to learn about the Long-term Care Initiative and to read the Research Prospectus.




About Us | Clinical Programs | Education Programs | Events
Consumer Products | Research | Related Links | Contact Us | Home
Text Only Access | University of Maryland School of Pharmacy | University of Maryland
University of Maryland School of Pharmacy

©2003 The Peter Lamy Center - All rights reserved.
Questions, comments or problems with our site? Please email lamycenterweb@rx.umaryland.edu

Home Contact Us